EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Value of OPNI in Hepatocellular Carcinoma

Jing Zhou, Daofeng Yang

Oncology · 2023

DOI: 10.1159/000530319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2023. Verfasst von Jing Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, zj202176330@…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The overall prognosis of patients with HCC is not very ideal. Early detection of HCC has become one of the important means to reduce mortality. More and more studies have pointed out that inflammatory markers based on hematology, such as Onodera’s prognostic nutritional index (OPNI), have important clinical significance. However, there is a lack of relevant research on the diagnosis of HCC by inflammatory markers.

Methods

We retrospectively enrolled 633 patients and prospectively recruited 121 consecutive patients, to explore the correlation between inflammatory markers and diagnosis of HCC. Based on the prognostic indicators, different diagnostic models were constructed and the diagnostic performance of different models was further compared.

Results

The best cutoff value of OPNI in the diagnosis of HCC is 43.925. Area under the receiver operating characteristics curve (AUC) of gender + age + AFP + OPNI diagnosis of HCC is 0.837 (95% CI: 0.702–0.868) in the retrospective cohort. Compared with gender + age + AFP, the Nagelkerke R2 of gender + age + AFP + OPNI increased from 0.234 to 0.426, and AUC increased by 0.0973 (95% CI: 0.0659–0.1290). DeLong test, net reclassification improvement (NRI) test, and integrated discrimination improvement (IDI) test are all statistically significant. In the prospective cohort, AUC of gender + age + AFP + OPNI diagnosis of HCC is 0.782 (95% CI: 0.696–0.869). Compared with gender + age + AFP, NRI test is statistically significant (categorical 0.0909 [95% CI: 0.0060–0.1759], p = 0.0359).

Conclusion

In the process of monitoring the occurrence of HCC in patients with risk factors, OPNI can be included as appropriate to improve the accuracy of HCC diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansNutrition AssessmentRetrospective Studiesalpha-FetoproteinsProspective StudiesROC CurveBiomarkers, Tumor

Stichwörter der Autor:innen

DiagnosisHepatocellular carcinomaOnodera’s prognostic nutritional index

Substanzen

alpha-FetoproteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, zj202176330@163.com.
  • Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Zhou, J., & Yang, D. (2023). Diagnostic Value of OPNI in Hepatocellular Carcinoma. Oncology. https://doi.org/10.1159/000530319

Vancouver

Zhou J, Yang D. Diagnostic Value of OPNI in Hepatocellular Carcinoma. Oncology. 2023. doi:10.1159/000530319

BibTeX
@article{Zhou2023,
  author = {Zhou, Jing and Yang, Daofeng},
  title = {Diagnostic Value of OPNI in Hepatocellular Carcinoma},
  journal = {Oncology},
  year = {2023},
  doi = {10.1159/000530319}
}
Kostenlos starten →